License agreement signed with Erasmus MC

ExoVectory has obtained the exclusive license from Erasmus MC, NL to further develop and commercialize the exosome loading technology. This includes developments in therapeutic areas including, but not limited to, gene therapy, cancer and vaccines for infectious diseases.

Explore our exosome delivery technology or contact ExoVectory about partnerships and investment.